ScholarIQanswers from OpenAlex & ORCID
Bhaskar Dasgupta
ResearcherPublications, citations & collaboration network
Bhaskar Dasgupta is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bhaskar Dasgupta have?
ScholarIQindexed works
Bhaskar Dasgupta has 338 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bhaskar Dasgupta have?
ScholarIQcitation count
Bhaskar Dasgupta has 19,240 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bhaskar Dasgupta?
ScholarIQh-index
Bhaskar Dasgupta has an h-index of 62 in OpenAlex.
What is the i10-index of Bhaskar Dasgupta?
ScholarIQi10-index
Bhaskar Dasgupta has an i10-index of 148 in OpenAlex.
What is the ORCID of Bhaskar Dasgupta?
ScholarIQorcid
The ORCID for Bhaskar Dasgupta is on the source record.
What is the OpenAlex record for Bhaskar Dasgupta?
ScholarIQopenalex
The OpenAlex for Bhaskar Dasgupta is on the source record.
What are the most-cited papers on Bhaskar Dasgupta?
ScholarIQmost cited works
Trial of Tocilizumab in Giant-Cell Arteritis
John H. Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer, Daniël Blockmans, Elisabeth Brouwer, María C. Cid, Bhaskar Dasgupta, Jürgen Rech, Carlo Salvarani, Georg Schett, Hendrik Schulze‐Koops, Robert Spiera, Sebastian Unizony, Neil Collinson
Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
Chetan Mukhtyar, R Lee, Denise Scott Brown, David Carruthers, Bhaskar Dasgupta, Shirish Dubey, Oliver Floßmann, Catherine Hall, J Hollywood, David Jayne, Rachel Jones, Peter Lanyon, Andrew J. Muir, David A. Scott, Lauren K. Young, Raashid Luqmani
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Bhaskar Dasgupta, Marco A. Cimmino, Hilal Maradit Kremers, Wolfgang Schmidt, Michael Schirmer, Carlo Salvarani, Artur Bachta, Christian Dejaco, Christina Duftner, Hanne Jensen, P. Duhaut, Gyula Poór, Novák Pál Kaposi, Péter Mandl, Péter Bálint, Zsuzsa Schmidt, Annamaria Iagnocco, Carlotta Nannini, Fabrizio Cantini, Pierluigi Macchioni, Nicolò Pipitone, Montserrat Del Amo, Georgina Espígol‐Frigolé, María C. Cid, Víctor M. Martínez‐Taboada, Elisabeth Nordborg, Haner Di̇reskeneli̇, Sibel Zehra Aydın, Khalid Ahmed, B L Hazleman, Barbara Silverman, Colin Pease, Richard J. Wakefield, Raashid Luqmani, Andy Abril, Clement J. Michet, Ralph Marcus, Neil Gonter, Mehrdad Maz, Rickey E. Carter, Cynthia S. Crowson, Eric L. Matteson
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
Frances Humby, Patrick Durez, Maya H Buch, Myles Lewis, Hasan Rizvi, Felice Rivellese, Alessandra Nerviani, Giovanni Giorli, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Michele Bombardieri, Vasco C. Romão, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar Dasgupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Robert J. Moots, Peter C. Taylor, Christopher J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Costantino Pitzalis, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, João Eurico Fonseca, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Liliane Fossati‐Jimack, Gaye Hadfield, Georgina Thorborn, Julio Ramírez, Raquel Celis
The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
Joanna Robson, Amit Kiran, Joe Maskell, Andrew Hutchings, Nigel Arden, Bhaskar Dasgupta, William Hamilton, Akan Emin, David Culliford, Raashid Luqmani